Contact Us: 01282 426380
KM Financial Solutions | Novartis, Merck and Allergan join those raising U.S. drug prices for 2020
60285
post-template-default,single,single-post,postid-60285,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

02 Jan Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

Posted at 16:42h in News by
0 Likes
Novartis AG, Merck & Co
Inc and Allergan Plc were among companies that
raised U.S. prices on more than 100 prescription medicines on
Friday, bringing the tally to 445 drugs that will cost more in
2020, according to data analyzed by healthcare research firm 3
Axis Advisors.

No Comments

Sorry, the comment form is closed at this time.